2|0|Public
5000|$|<b>Delanterone</b> (GBR-21162): An AR {{antagonist}} {{which was}} described in the literature in 1977. Was under development {{for the treatment of}} acne but showed poor effectiveness in preclinical studies and was abandoned.|$|E
50|$|<b>Delanterone</b> (INN) (developmental {{code name}} GBR-21162), {{also known as}} 1Î±-methylandrosta-4,16-dien-3-one, is a steroidal {{antiandrogen}} described as an anti-acne agent which was never marketed. The compound showed poor efficacy as an antiandrogen in vivo in animals, suggestive of low activity or a short terminal half-life, and likely in relation to this was not further developed. It was described and characterized in the literature in 1977.|$|E

